In 2022, Kwang Dong Pharmaceutical had an operating profit of around 38.24 billion South Korean won. This represents a decrease from the previous year. Operating profit peaked in 2015 at nearly 51 billion won. The company is mainly involved with the manufacturing and distribution of pharmaceuticals. Kwang Dong Pharmaceuticals is considered one of
Consolidated operating profit of Kwang Dong Pharmaceutical Co., Ltd. from 2011 to 2022 (in billion South Korean won)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
9
- Premium Statistic Revenue from pharmaceutical manufacturer in Denmark 2009-2023
- Basic Statistic Responsibility of pharmaceutical firms to provide complementary services 2013
- Basic Statistic Preferred services from a pharmaceutical company 2013
- Basic Statistic Satisfaction or desire for received pharmaceutical services in the U.S. 2013
- Basic Statistic Top five services from pharma companies for U.S. patients 2013
- Basic Statistic Proactive patients in reviewing select health information and issues 2013
- Premium Statistic Production in European pharmaceutical industry by country 2021
- Basic Statistic Employment in EFPIA pharmaceutical industry 1990-2022
- Basic Statistic Members of EFPIA's pharmaceutical exports and imports 1990-2022
About the region
10
- Premium Statistic Sales revenue distribution of JW Pharmaceutical South Korea 2022, by channel
- Premium Statistic Sales revenue of JW Pharmaceutical 2014-2022
- Premium Statistic Operating profit of JW Pharmaceutical 2014-2022
- Premium Statistic R&D spending of JW Pharmaceutical South Korea 2014-2022
- Premium Statistic R&D spending ratio of JW Pharmaceutical South Korea 2014-2022
- Premium Statistic Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Premium Statistic Market share of Celltrion's Truxima in Europe Q2 2017-Q2 2018
- Premium Statistic Net income Yuhan 2015-2022
- Premium Statistic Sales revenue Celltrion 2013-2022
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2023
Selected statistics
10
- Basic Statistic Merck & Co total assets 2009-2023
- Premium Statistic Merck & Co - expenditure on research and development 2006-2023
- Premium Statistic Sales of Johnson & Johnson 2006-2023 by region
- Basic Statistic Merck & Co cash dividends declared 2006-2023
- Basic Statistic Sanofi's total assets 2007-2023
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2023
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2023
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Premium Statistic Johnson & Johnson's number of employees 2004-2023
- Basic Statistic GSK's operating profit by division 2006-2021
Other regions
8
- Premium Statistic Total equity of the Ipsen group 2014-2019
- Basic Statistic Total U.S. pharma and biotech product sales 5 years after launch 2007-2021
- Premium Statistic Total assets of the Ipsen group 2014-2019
- Premium Statistic Italy: number of R&D employees of biotech pharma companies 2014-2017
- Premium Statistic Members of EFPIA's pharmaceutical R&D spending 1990-2022
- Premium Statistic Pharmaceutical sales volume in Mexico 2021, by segment
- Premium Statistic Latin America: main pharmacies 2017, by number of stores
- Premium Statistic Venezuela: pharma industry market value 2008-2017
Related statistics
10
- Premium Statistic Net profit Hanmi Pharmaceutical 2017-2022
- Premium Statistic R&D investment Hanmi Pharmaceutical 2017-2022
- Premium Statistic Sales revenue from non-prescription drugs Yuhan 2016-2022
- Premium Statistic Sales revenue from medicine raw material exports Yuhan 2016-2023
- Premium Statistic Operating income Yuhan 2015-2022
- Premium Statistic Impact of COVID-19 on OTC pharmacy sales South Korea 2020
- Premium Statistic Leading pharmaceutical businesses South Korea 2023, by revenue
- Premium Statistic Sales revenue of GC Pharma 2015-2023
- Premium Statistic Revenue of Chong Kun Dang 2015-2023
- Premium Statistic Sales revenue Samsung Biologics 2015-2023
Further related statistics
10
- Pfizer's ad spending 2006-2023
- Celgene's revenue and net income 2006-2018
- M&A capacities - changes for the global pharma industry 2008-2015
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
- Revenue of Sinopharm 2011-2022, by category
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Key figures on established biotech centers worldwide 2012-2016
- Expenditure worldwide on diabetes by market 2013-2018
- AstraZeneca's revenue from top product Pulmicort 2006-2023
Further Content: You might find this interesting as well
Statistics
- Pfizer's ad spending 2006-2023
- Celgene's revenue and net income 2006-2018
- M&A capacities - changes for the global pharma industry 2008-2015
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
- Revenue of Sinopharm 2011-2022, by category
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Key figures on established biotech centers worldwide 2012-2016
- Expenditure worldwide on diabetes by market 2013-2018
- AstraZeneca's revenue from top product Pulmicort 2006-2023
DART. (March 16, 2023). Consolidated operating profit of Kwang Dong Pharmaceutical Co., Ltd. from 2011 to 2022 (in billion South Korean won) [Graph]. In Statista. Retrieved June 01, 2024, from https://www.statista.com/statistics/1269713/kwang-dong-pharmaceutical-operating-profit/
DART. "Consolidated operating profit of Kwang Dong Pharmaceutical Co., Ltd. from 2011 to 2022 (in billion South Korean won)." Chart. March 16, 2023. Statista. Accessed June 01, 2024. https://www.statista.com/statistics/1269713/kwang-dong-pharmaceutical-operating-profit/
DART. (2023). Consolidated operating profit of Kwang Dong Pharmaceutical Co., Ltd. from 2011 to 2022 (in billion South Korean won). Statista. Statista Inc.. Accessed: June 01, 2024. https://www.statista.com/statistics/1269713/kwang-dong-pharmaceutical-operating-profit/
DART. "Consolidated Operating Profit of Kwang Dong Pharmaceutical Co., Ltd. from 2011 to 2022 (in Billion South Korean Won)." Statista, Statista Inc., 16 Mar 2023, https://www.statista.com/statistics/1269713/kwang-dong-pharmaceutical-operating-profit/
DART, Consolidated operating profit of Kwang Dong Pharmaceutical Co., Ltd. from 2011 to 2022 (in billion South Korean won) Statista, https://www.statista.com/statistics/1269713/kwang-dong-pharmaceutical-operating-profit/ (last visited June 01, 2024)
Consolidated operating profit of Kwang Dong Pharmaceutical Co., Ltd. from 2011 to 2022 (in billion South Korean won) [Graph], DART, March 16, 2023. [Online]. Available: https://www.statista.com/statistics/1269713/kwang-dong-pharmaceutical-operating-profit/